A settlement has been reached to resolve False Claims Act allegations against Cardiovascular Systems Inc.
The allegations arose from a lawsuit, which was filed July 2013, claiming that Cardiovascular Systems persuaded physicians to use its products by offering free, all-expense-paid training programs “followed by explicit demands by CSI employees that attendees use CSI products on future patients,” giving away product for free, 3rd-party referral channel marketing, and “sham Speaker Bureau payments for high-prescribers and others whom CSI sought to cultivate,” according to the complaint filed in the U.S. District Court for Western North Carolina.
Cardiovascular Systems was also accused of running an off-label promotion scheme to push sales of its unapproved 4 French catheter.
These allegations were brought forward by a former employee of Cardiovascular Systems Inc.
